Prior status of graft‐versus‐host disease affects donor lymphocyte infusion outcomes in patients with relapsed haematological malignancies after allogeneic stem cell transplantation

Documents similaires

• The addition of doxycycline to fluoroquinolones for bacterial prophylaxis in autologous stem cell transplantation for multiple myeloma
  par: Emma G. Guare, et autres
  Publié: (2024)
• Induction of remission after donor lymphocyte infusion following allogeneic transplant in a case of pediatric primary myelofibrosis
  par: Amy Li, et autres
  Publié: (2024)
• HLA evolutionary divergence score after donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation
  par: Sophie Le Grand, et autres
  Publié: (2025)
• Outcomes and risk factors of second allogeneic haematopoietic stem cell transplantation in patients with relapsed haematological malignancy after first transplantation
  par: Xiaolu Zhu, et autres
  Publié: (2025)
• Mega‐dose decitabine conditioning and prophylactic donor lymphocyte infusion for patients with relapsed/refractory AML with active disease at the time of allogeneic haematopoietic cell transplantation: A multicenter prospective phase II study
  par: Meng Lv, et autres
  Publié: (2024)